LEONHARDT VENTURES NEWS
Executive Office Review 2020 Full Year Financials
Cal-X Stars Business Accelerator, Inc. DBA Leonhardt's Launchpads Executive Office Review 2020 Full Year Financials Expenses Cash Wages = $153,645 - All members including CEO - Incredibly modest for company with over 600 patent claims and multiple products in clinical...
2021 LETTER TO STAKEHOLDERS
A highly FOCUSED organization on the brink of major contributions to healthcare Dear Stakeholders, It is truly an honor to serve as Executive Chairman and CEO of Leonhardt’s Launchpads by Cal-X Stars Business Accelerator, Inc. the innovation and startup accelerator...
Top Achievements by Each Development Team 2020
Heart & Cardiovascular Group https://leonhardtventures.com/heart-and-cardiovascular/ Second Heart Assist Long duration pre-clinical studies successful - Texas Heart Institute including video interview at THI. 109 hours plus in mock loop systems. 10 hour CRS...
Leonhardt’s Launchpads Executive Chairman & CEO Year End 2020 Stakeholder Update
Irvine, California, December 15th, 2020 – Leonhardt’s Launchpads by Cal-X Stars Business Accelerator, Inc. is an innovation accelerator HIGHLY FOCUSED on organ regeneration and recovery based on a common IP platform of bioelectrics and biologics –...
Coronvirus Covid-19 Prevention and Treatment Patent Filed
ABSTRACT: Described are methods of treating a mammalian subject who is intending to undergo exposure to...
LEONHARDT’S LAUNCHPADS ORGAN REGENERATION INNOVATION ACCELERATOR COMPLETES MOVE OF HEADQUARTERS TO IRVINE, CALIFORNIA
Leonhardt's Launchpads innovation accelerator completes move of its headquarters to the wet lab incubator operated by University Lab Partners in a specialized fully equipped and staffed facility in Irvine, California. IRVINE, Calif., November 24th, 2020 -...
Second Heart Assist Files Patent for Electro-Activated Shape Changing Impeller for Circulatory Assist Devices
Salt Lake City, Utah and Irvine, CA Nov. 17th, 2020 (PR Distribution) -- Second Heart Assist, Inc. has filed a patent application with the United States Patent and Trademark Office (USPTO) covering numerous claims for the utilization of electro-active polymers and...
BladderCell Launches Bioelectric Treatment Clinical Study for Incontinence adding Pelvic Stimulation
Study Designed to Further Confirm Safety, Efficacy and Patient Benefit of BladderCell Non-Invasive Bioelectric Stimulation Treatment for Bladder Dysfunction Incontinence Porto Alegre, Brazil and Irvine, California, October 23rd, 2020 (PR Distribution) -- BladderCell,...
Pioneering Pilot Study Launching for Combination of Bioelectric Simulation Controlled Protein Expressions and Mixed Biologics for Bladder Function Recovery
The BladderCell III study is examining for the first time the combination of bioelectrics and biologics for bladder function recovery. Irvine, California and Porto Alegre, Brazil - Study is aimed to establish the initial pilot safety and efficacy of the BladderCell...
Use of bioelectric stimulation to rehabilitation of critical patients with COVID-19
Principal Investigator: Rodrigo Della Méa Plentz, PhD Telephone: +55 (51) 991131651 Email: roplentz@yahoo.com.br Co-Principal Investigator: Jociane Schardong, PhD Telephone: +55 (55) 981348114 Email: joci_fisioufsm@yahoo.com.br Location of Study: Intensive Care Unit...